Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids

Citation
O. Kafrawy et al., Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids, CANCER LETT, 132(1-2), 1998, pp. 23-29
Citations number
18
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
132
Issue
1-2
Year of publication
1998
Pages
23 - 29
Database
ISI
SICI code
0304-3835(19981023)132:1-2<23:DAIPMC>2.0.ZU;2-9
Abstract
We reported previously that docosahexaenoic acid (22:6)-containing phosphat idylcholine (PC), but not oleic acid-containing PC nor 22:6-containing phos phatidylethanolamine, is toxic to tumor cells in vitro. To test whether oth er polyunsaturated fatty acids share 22:6's cytotoxic activity, we treated cultured T27A murine leukemia cells with PC liposomes composed of stearic a cid in the sn-1 position and alpha-linolenic acid (alpha-18:3), arachidonic acid (20:4), or eicosapentaenoic acid (20:5) in the sn-2 position. PC cont aining 22:6 in both positions was also tested. Following treatment, the cel ls were monitored for fatty acid composition, liposome uptake and viability . Here we demonstrate that cytotoxicity is unique to 22:6-containing PCs an d is not shared by PCs with other polyunsaturated omega-3 and omega-6 fatty acids. Because PCs with fatty acids other than 22:6 were taken up by cells but did not kill the cells, we propose that 22:6-containing PCs incorporat ed into cellular membranes produce unique changes in the membrane structure incompatible with cell survival. PC liposomes containing 22:6 are potentia l drug delivery vehicles that may, by virtue of their cytotoxicity, serve c oncomitantly as adjunct cancer therapy. (C) 1998 Elsevier Science Ireland L td. All rights reserved.